Broadfin Capital, LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$5,963,000
-82.8%
664,800
-89.7%
0.53%
-84.1%
Q2 2016$34,637,000
+7.6%
6,450,000
-7.9%
3.37%
+8.3%
Q1 2016$32,200,000
+156.6%
7,000,000
+190.1%
3.11%
+302.8%
Q4 2015$12,548,000
+46.8%
2,412,995
+70.8%
0.77%
+62.2%
Q3 2015$8,549,000
-59.0%
1,412,995
+7.1%
0.48%
-57.5%
Q2 2015$20,841,000
+6254.0%
1,319,883
+4141.8%
1.12%
+7900.0%
Q4 2014$328,00031,1160.01%
Other shareholders

There were no reported owners of RAPTOR PHARMACEUTICAL CORP in Q3 2016.

NameSharesValueWeighting ↓
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders